172 related articles for article (PubMed ID: 20426858)
21. Head and neck mucosal melanoma.
Mendenhall WM; Amdur RJ; Hinerman RW; Werning JW; Villaret DB; Mendenhall NP
Am J Clin Oncol; 2005 Dec; 28(6):626-30. PubMed ID: 16317276
[TBL] [Abstract][Full Text] [Related]
22. Risk-based stratification in head and neck mucosal melanoma.
Moya-Plana A; Mangin D; Dercle L; Taouachi R; Casiraghi O; Ammari S; Nguyen F; Temam S; Robert C; Gorphe P
Oral Oncol; 2019 Oct; 97():44-49. PubMed ID: 31421470
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of two tumour staging classifications in patients with sinonasal mucosal melanoma.
Houette A; Gilain L; Mulliez A; Mom T; Saroul N
Eur Ann Otorhinolaryngol Head Neck Dis; 2016 Nov; 133(5):313-317. PubMed ID: 27291483
[TBL] [Abstract][Full Text] [Related]
24. Primary noncutaneous melanoma.
Wu E; Golitz LE
Clin Lab Med; 2000 Dec; 20(4):731-44. PubMed ID: 11221512
[TBL] [Abstract][Full Text] [Related]
25. Outcome of patients following hepatic resection for metastatic cutaneous and ocular melanoma.
Caralt M; Martí J; Cortés J; Fondevila C; Bilbao I; Fuster J; García-Valdecasas JC; Sapisochín G; Balsells J; Charco R
J Hepatobiliary Pancreat Sci; 2011 Mar; 18(2):268-75. PubMed ID: 21057964
[TBL] [Abstract][Full Text] [Related]
26. Multicenter Study of Carbon-Ion Radiation Therapy for Mucosal Melanoma of the Head and Neck: Subanalysis of the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS) Study (1402 HN).
Koto M; Demizu Y; Saitoh JI; Suefuji H; Tsuji H; Okimoto T; Ohno T; Shioyama Y; Takagi R; Nemoto K; Nakano T; Kamada T;
Int J Radiat Oncol Biol Phys; 2017 Apr; 97(5):1054-1060. PubMed ID: 28332989
[TBL] [Abstract][Full Text] [Related]
27. Survival and Surgical Outcomes for Pediatric Head and Neck Melanoma.
Richards MK; Czechowicz J; Goldin AB; Gow KW; Doski J; Goldfarb M; Nuchtern J; Langer M; Beierle EA; Vasudevan S; Gupta D; Parikh SR
JAMA Otolaryngol Head Neck Surg; 2017 Jan; 143(1):34-40. PubMed ID: 27607058
[TBL] [Abstract][Full Text] [Related]
28. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial.
Burmeister BH; Henderson MA; Ainslie J; Fisher R; Di Iulio J; Smithers BM; Hong A; Shannon K; Scolyer RA; Carruthers S; Coventry BJ; Babington S; Duprat J; Hoekstra HJ; Thompson JF
Lancet Oncol; 2012 Jun; 13(6):589-97. PubMed ID: 22575589
[TBL] [Abstract][Full Text] [Related]
29. Treatments for noncutaneous melanoma.
Khalil DN; Carvajal RD
Hematol Oncol Clin North Am; 2014 Jun; 28(3):507-21. PubMed ID: 24880944
[TBL] [Abstract][Full Text] [Related]
30. Effect of paclitaxel/carboplatin salvage chemotherapy in noncutaneous versus cutaneous metastatic melanoma.
Chang W; Lee SJ; Park S; Choi MK; Hong JY; Kim YS; Maeng CH; Jung HA; Kim S; Lee J
Melanoma Res; 2013 Apr; 23(2):147-51. PubMed ID: 23411477
[TBL] [Abstract][Full Text] [Related]
31. Evolving Therapeutic Strategies in Mucosal Melanoma Have Not Improved Survival Over Five Decades.
Kirchoff DD; Deutsch GB; Foshag LJ; Lee JH; Sim MS; Faries MB
Am Surg; 2016 Jan; 82(1):1-5. PubMed ID: 26802836
[TBL] [Abstract][Full Text] [Related]
32. Identification and clinical relevance of PD-L1 expression in primary mucosal malignant melanoma of the head and neck.
Thierauf J; Veit JA; Affolter A; Bergmann C; Grünow J; Laban S; Lennerz JK; Grünmüller L; Mauch C; Plinkert PK; Hess J; Hoffmann TK
Melanoma Res; 2015 Dec; 25(6):503-9. PubMed ID: 26352784
[TBL] [Abstract][Full Text] [Related]
33. Clinical features and survival outcomes of ocular melanoma in a multi-ethnic Asian cohort.
Tan LLY; Hong J; Goh WL; Chang EWY; Yang VS; Poon E; Somasundaram N; Farid M; Chan ASY; Chan JY
Sci Rep; 2020 Oct; 10(1):16367. PubMed ID: 33004998
[TBL] [Abstract][Full Text] [Related]
34. Oncologic outcomes, prognostic factor analysis and therapeutic algorithm evaluation of head and neck mucosal melanomas in France.
Moya-Plana A; Aupérin A; Obongo R; Baglin A; Ferrand FR; Baujat B; Saroul N; Casiraghi O; Vergez S; Herman P; Janot F; Thariat J; Vérillaud B; de Gabory L;
Eur J Cancer; 2019 Dec; 123():1-10. PubMed ID: 31670075
[TBL] [Abstract][Full Text] [Related]
35. Role of adjuvant chemotherapy in malignant mucosal melanoma of the head and neck.
Ahn HJ; Na II; Park YH; Cho SY; Lee BC; Lee GH; Koh JS; Lee YS; Shim YS; Kim YK; Kang HJ; Ryoo BY; Yang SH
Oral Oncol; 2010 Aug; 46(8):607-11. PubMed ID: 20615750
[TBL] [Abstract][Full Text] [Related]
36. Survival outcomes of mucosal melanoma in the USA.
Al-Haseni A; Vrable A; Qureshi MM; Mathews S; Pollock S; Truong MT; Sahni D
Future Oncol; 2019 Dec; 15(34):3977-3986. PubMed ID: 31724885
[No Abstract] [Full Text] [Related]
37. Prognostic score for patients with advanced melanoma treated with ipilimumab.
Diem S; Kasenda B; Martin-Liberal J; Lee A; Chauhan D; Gore M; Larkin J
Eur J Cancer; 2015 Dec; 51(18):2785-91. PubMed ID: 26597444
[TBL] [Abstract][Full Text] [Related]
38. Nodal and distant metastases in sinonasal mucosal melanoma: A population-based analysis.
Low CM; Price DL; Moore EJ; Stokken JK; Van Abel KM; Janus JR; Choby G
Laryngoscope; 2020 Mar; 130(3):622-627. PubMed ID: 31077407
[TBL] [Abstract][Full Text] [Related]
39. [Analysis of prognostic factors of primary mucosal melanoma in nasal and oral cavity].
Lin JW; Li CW; Wu GH; Zeng ZY
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Jan; 26(2):49-52. PubMed ID: 22500456
[TBL] [Abstract][Full Text] [Related]
40. Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma.
Harcharik S; Bernardo S; Moskalenko M; Pan M; Sivendran M; Bell H; Hall LD; Castillo-Martín M; Fox K; Cordon-Cardo C; Chang R; Sivendran S; Phelps RG; Saenger Y
J Am Acad Dermatol; 2014 Jun; 70(6):1036-44. PubMed ID: 24698703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
